In vivo IL-6 and IL-8 secretion would stimulate neoangiogenesis to deliver oxygen and nutrients to the growing tumor whereas in vitro the result could be the increased microtumor growth and maintenance we observed during our validation studies. The gene discussed is CXCL8; the disease is neoplasm.